Paediatric oncology
Prof Dr Miriam Erlacher, Prof Dr Holger Cario, Prof Dr Lüder Hinrich Meyer, Prof Dr Ansgar Schulz, Prof Dr Manfred Hönig
3 - 6 months
Visiting Residency and Visiting Observership
A minimum of intermediate level B2 in German (for residency: to be approved by the Regional Administrative Council/Supreme Health Authority of the German State of Baden-Wuerttemberg). Fluent English.
Programme description
About 85 patients suffering from malignant diseases are seen and treated at our Paediatric Oncology Centre (special ward, day-care clinic and outpatient unit), which include solid tumours, leukaemias and lymphomas, central nervous system tumours and dysfunctions of haematopoiesis. In addition, we offer a number of novel innovative therapeutic concepts, many of which were developed at our hospital. Specific treatment of leukaemia, bone marrow failure and immunodeficiency through bone marrow and stem cell transplantation has been a major focus over the past 40 years (record of >1000 transplant patients). As national reference center for pediatric myelodysplastic syndrome and juvenile myelomonocytic leukemia within the European Working Group we offer to join our diagnostic team. Rare bone marrow diseases are explored intensively by microscope morphology but also relying on histopathology and molecular genetic testing. Participants will be involved in diagnosis and treatment in the in- and outpatient setting, attending tumour boards, planning and application of anti-neoplastic therapies as well as diagnosis and treatment of corresponding side effects.
For residency status, it is mandatory for applicants to hold a ‘Medical license for temporary practice in the State of Baden-Wuerttemberg, Germany’ issued by the ‘Regierungspraesidium Stuttgart’ (Regional Administrative Council/Supreme Health Authority of the State of Baden-Wuerttemberg, Germany).
